Log in

Wisconsin Dermatological Society
Virtual SPRING Meeting

SATURday, may 1, 2021

Participate online live or watch the recording at your convenience.
CME & MOC credit are available for real-time participation only. 

Agenda

 
8:45 a.m. - 1:45 p.m.
Pharmaceutical Exhibitors Available
View Posters

9:00 a.m.
Welcome
9:05 a.m.
UW-Madison Faculty Lecture: Lisa Arkin, MD
"Leveraging COVID toes: mapping an exceptional innate immune response to SARS-CoV-2" "
9:30 a.m.

Interesting Cases from UW-Madison Dermatology

  • John Moon, MD – Vascular Malformations and PI3K-inhibitors
  • Aman Prasad, MD – Oral Sirolimus in the Treatment of a Challenging Case of Pediatric Subacute Cutaneous Lupus Erythematosus
  • Annika Weinhammer, MD – Fever of unknown origin + subcutaneous nodules
10:30 a.m.
Interesting Cases from UW-Madison Dermatology
  • Kyle Rudningen, MD – Squamous cell carcinoma lacking histologic continuity to the epidermis: a clinical approach
  • Nadine Shabeeb, MD – Emerging Medical Treatments for Hidradenitis Suppurativa
  • Josh Eicksaedt, MD – Chronic Sequelae Secondary to Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
11:30 a.m.

George T. Reizner, MD, Lecture: Bethanee Schlosser, M.D.
"Vulvar Mucosal Disease: Necessities and Nuances for Dermatologists"

12:30 p.m.
Meeting Adjourned
12:35 p.m.-1:35 p.m.

Sponsor Breakout Rooms

1:15 p.m.-1:45 p.m.
WDS Business Meeting


Presenters

 

Lisa Arkin, MD is currently the Director of Pediatric Dermatology, an Assistant Professor of Dermatology & Pediatrics and serves as the Co-Director of the Birthmarks and Vascular Anomalies Center (BVAC) at the University of Wisconsin School of Medicine and Public Health. She is currently the chair of the Pediatric Dermatology Research Alliance Early Investigator's Committee, and responsible for creation of programming directed for trainees and junior faculty <7 years out of fellowship.

Her current research involves investigation of patients with so-called "COVID toes," with banked tissue including serial blood, saliva and skin biopsies. The intention of this work is to solidify the genetic and immune signature in these patients to catalyze therapeutics for those at risk for severe COVID.

She also has a Dermatology Foundation-funded project starting this spring to find a precision-based treatment for patients with port wine stains. This project will leverage novel imaging utilizing optical coherence tomography and genotyping to determine more precise treatment parameters for these patients. As part of that project, she and Dr. Beth Drolet are utilizing spatial transcriptomics to map downstream pathways in patients with known GNAQ/GNA11 mutations to elucidate molecular targets for pharmacologic intervention.


Bethanee Schlosser, MD has dedicated her career to advancing the field of women’s skin health and to improving the lives of women and girls through education, clinical care, and investigative research. Dr. Schlosser is an internationally recognized expert in female genital (vulvar) mucosal disorders, acne, rosacea, skin disorders in pregnancy, and excess hair disorders in women.  For more than twelve years, Dr. Schlosser served as full-time faculty in the Departments of Dermatology and Obstetrics/Gynecology at Northwestern University, serving as Director of Women’s Skin Health Program, Vulvar Mucosal Specialty Clinic, and Skin Concerns in Pregnancy Clinic.  She is currently devoting her time to caring for her immediate and extended family in the context of the COVID pandemic.

Dr. Schlosser attended Bucknell University.  She earned her MD and her PhD in Cell and Molecular Biology from Pennsylvania State University College of Medicine in 2003. Dr. Schlosser completed an internship at Mayo Clinic and performed her residency in Dermatology at Emory University.

Dr. Schlosser serves in leadership roles for various medical organizations including the Women’s Dermatologic Society, the American Acne and Rosacea Society and the American Academy of Dermatology.

UW-Madison Resident Presenters

Josh Eickstaedt, MD
Chronic Sequelae Secondary to Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
John Moon, MD
Vascular Malformations and PI3K-inhibitors

Aman Prasad, MD, PhD
Oral Sirolimus in the Treatment of a Challenging Case of Pediatric Subacute Cutaneous Lupus Erythematosus
Kyle Rudningen, MD
Squamous Cell Carcinoma Lacking Histologic Continuity to the Epidermis: a Clinical Approach

 
 
Nadine Shabeeb, MD
Emerging Medical Treatments for Hidradenitis Suppurativa
Annika Weinhammer, MD
Fever of Unknown Origin + Subcutaneous Nodules





Details

 

Participate online live or watch the recording at your convenience.
CME & MOC credit for physicians are available for real-time participation only.


Cost

WDS Members: Free
Residents: Free
Non-Members: $100, includes 1-year membership
No refunds will be given.

Questions
Dana Kader Robb, widermsociety@gmail.com


CME Credit
To receive CME credit, you will need to enroll in Ethos, the MCW CME system. Instructions will be sent via email after registration.

ACCME Accreditation Statement
The activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and the Wisconsin Dermatological Society.  The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement
The Medical College of Wisconsin designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 3.25 hours of participation for continuing education for allied health professionals.

Target Audience and Scope of Practice
This program is intended for dermatologists, dermatopathologists, dermatologic surgeons, nurse practitioners, physician assistants, WDS members, and other allied healthcare providers who work with patients that have dermatologic diseases. The secondary target audience is dermatology residents.

Educational Purpose
To keep dermatology providers abreast of relevant new clinical knowledge and dermatological skills, in order to provide quality medical care for their patients, and improved healthcare outcomes.

ADA Statement
The Wisconsin Dermatological Society fully intends to comply with the legal requirements of the Americans with Disabilities Act. If any participant of the conference is in need of accommodations, please call 414-750-4404.




Powered by Wild Apricot Membership Software